Conditions We Treat in Neuromuscular Disease
Our Neuromuscular Disease Clinic treatment options are wide-ranging and take in care for the following pediatric neuromuscular disorders:
- Muscular dystrophy – a group of genetic and progressive muscular diseases in which muscle fibers are highly susceptible to damage
- Spinal muscular atrophy (SMA) – a group of genetic diseases that weaken and even cause the wasting away of the voluntary muscles in the arms and legs of infants and children
- SPINRAZA™ (nusinersen) is a prescription medicine used to treat spinal muscular atrophy (SMA) in pediatric and adult patients.
- Congenital myopathy – Congenital (at birth) myopathy refers to a group of muscle disorders that can make an infant appear “floppy” and negatively impacts breathing or feeding. An affected child will display developmental delay.
- Myotonic dystrophy – a hereditary form of muscular dystrophy that affects the muscles and other body systems
- Myasthenia gravis – a chronic autoimmune neuromuscular disease characterized by different degrees of skeletal muscle weakness
- Charcot-Marie-Tooth Disease – a group of inherited disorders that affect the peripheral nervous system. Affected children suffer a progressive loss of muscle tissue and touch sensation in various parts of the body.
- Guillain-Barre Syndrome – a condition where the body’s immune system attacks part of the peripheral nervous system
- Chronic Inflammatory Demyelinating Polyneuropathy – a disorder characterized by progressive weakness and impaired sensory function in the legs and arms. Damage to the myelin sheath (which protects nerve fibers) causes the disease.
The Neuromuscular Disease Clinic at Children’s Medical Center is officially sponsored by the Muscular Dystrophy Association. Please visit http://mda.org/publications/factsabout for more information regarding specific disease processes.